Merck and Eisai said on Friday a combination of their cancer therapies failed to extend the lives of patients with a type of ...

A team of researchers from NUS has developed a novel method to enhance the precision of cancer treatment using gold ...

Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...

A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in ...

Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment ...

"During Joe Rogan’s podcast on Jan. 9, Mel Gibson promoted drugs that are not scientifically proven cancer treatments," the ...

Johnson & Johnson beat Wall Street’s fourth-quarter expectations as strong cancer drug sales compensated for a decline in ...

Johnson & Johnson, fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular, reported fourth-quarter sales ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

A medical startup claimed its blood filtering device could cure cancer. But multiple patients who used it died not long after.